Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Broadwind
BWEN
$93.6M
| $118K | ﹤0.01% |
65,400
+4,200
| +7% | +$7.09K |
|
3277
Sono-Tek
SOTK
$81.3M
| $116K | ﹤0.01% |
31,000
-1,200
| -4% | -$4.55K |
|
|
CMBM
3278
DELISTED
Cambium Networks
CMBM
| $116K | ﹤0.01% |
286,427
-165,056
| -37% | -$64.2K |
|
3279
Loop Industries
LOOP
$35.3M
| $116K | ﹤0.01% |
+81,428
| New | +$98.4K |
|
3280
Q32 Bio
QTTB
$466M
| $115K | ﹤0.01% |
+77,000
| New | +$131K |
|
|
DRRX
3281
DELISTED
DURECT Corp
DRRX
| $113K | ﹤0.01% |
177,766
+5,300
| +3% | +$3.42K |
|
3282
Wheels Up
UP
$208M
| $112K | ﹤0.01% |
+5,225
| New | +$128K |
|
3283
Xilio Therapeutics
XLO
$59.9M
| $112K | ﹤0.01% |
11,729
-964
| -8% | -$10.2K |
|
3284
Freightos
CRGO
$59.4M
| $112K | ﹤0.01% |
45,900
+17,400
| +61% | +$38.6K |
|
3285
Ribbon Communications
RBBN
$377M
| $110K | ﹤0.01% |
27,500
-117,312
| -81% | -$423K |
|
3286
Lipocine
LPCN
$17.5M
| $110K | ﹤0.01% |
34,797
-2,713
| -7% | -$8.8K |
|
3287
SCYNEXIS
SCYX
$48.1M
| $108K | ﹤0.01% |
19,975
+275
| +1% | +$1.93K |
|
|
HLVX
3288
DELISTED
HilleVax
HLVX
| $108K | ﹤0.01% |
54,100
+26,500
| +96% | +$48.5K |
|
3289
Vertical Aerospace
EVTL
$158M
| $107K | ﹤0.01% |
15,800
-6,909
| -30% | -$32.4K |
|
3290
Marker Therapeutics
MRKR
$18.8M
| $106K | ﹤0.01% |
69,442
-14,073
| -17% | -$18.1K |
|
3291
Forafric Global
AFRI
$289M
| $106K | ﹤0.01% |
13,600
+1,000
| +8% | +$8.05K |
|
3292
Bolt Biotherapeutics
BOLT
$7.67M
| $106K | ﹤0.01% |
18,325
+2,618
| +17% | +$17.3K |
|
3293
BTCS Inc
BTCS
$51.3M
| $105K | ﹤0.01% |
+47,900
| New | +$102K |
|
3294
Oric Pharmaceuticals
ORIC
$1.15B
| $104K | ﹤0.01% |
+10,200
| New | +$68.5K |
|
3295
Arena Group
AREN
$57.1M
| $103K | ﹤0.01% |
16,600
-21,200
| -56% | -$104K |
|
3296
Codere Online
CDRO
$417M
| $101K | ﹤0.01% |
+11,900
| New | +$88.5K |
|
3297
Southland Holdings
SLND
$30.2M
| $100K | ﹤0.01% |
+24,000
| New | +$84.7K |
|
|
BNR
3298
Burning Rock Biotech
BNR
$93.9M
| $100K | ﹤0.01% |
31,717
| – | – |
|
3299
Dominari Holdings
DOMH
$57.4M
| $97.5K | ﹤0.01% |
17,926
-30,200
| -63% | -$147K |
|
3300
Siebert Financial
SIEB
$66.7M
| $97.2K | ﹤0.01% |
22,000
-16,800
| -43% | -$68.2K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.